|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 259.60 EUR | -0.88% |
|
+1.76% | +10.47% |
| 06-25 | US prices for new drugs fell in 2025 as fewer costly gene therapies were launched | RE |
| 06-22 | UBS Trims UCB's PT, Affirms Buy Rating | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +4.73% | +5.50% | +8.52% | -14.12% | -15.24% | +19.45% | -8.94% | +12.10% | +82.50% | 63.56B | |
| +0.72% | +40.60% | +40.60% | +40.60% | +40.60% | +40.60% | +40.60% | +40.60% | - | 41.68B | |
| +3.69% | +6.09% | +32.12% | -13.14% | -29.41% | -49.43% | -55.88% | -56.78% | +8.43% | 39.12B | |
| +3.04% | +7.01% | +14.45% | +21.87% | +22.80% | +62.26% | -24.13% | -38.02% | -11.81% | 30.97B | |
| +10.01% | +33.49% | +74.76% | +62.11% | +170.46% | +163.41% | -34.35% | -65.96% | - | 28.77B | |
| +2.68% | +8.68% | +26.69% | +21.82% | +18.32% | +71.42% | +87.73% | +39.82% | +43.79% | 22.74B | |
| +2.40% | +16.43% | +13.86% | -2.02% | +14.75% | +3.43% | +191.67% | -1.69% | - | 17.64B | |
| +2.43% | +2.04% | +10.25% | +19.66% | +44.11% | +68.04% | +127.95% | +202.21% | +362.49% | 16.66B | |
| +3.58% | +10.76% | +20.84% | +5.52% | +0.92% | +80.22% | +348.78% | +20.89% | - | 14.6B | |
| +1.52% | +2.94% | +9.97% | +44.99% | +33.77% | +135.12% | +239.98% | +269.94% | +3,170.55% | 12.38B | |
| -1.82% | -6.27% | -1.54% | -0.14% | -21.80% | -10.45% | +718.39% | +359.98% | +5,704.59% | 12.37B | |
| +2.02% | +2.86% | +10.63% | +6.29% | -0.74% | +3.18% | -31.95% | -30.98% | -27.51% | 11.18B | |
| +0.94% | +4.21% | +27.92% | +43.73% | +52.13% | +165.35% | +219.48% | +435.81% | - | 10.95B | |
| +1.13% | +32.94% | +41.55% | -5.09% | +44.00% | +60.94% | +401.94% | +330.20% | - | 7.72B | |
| -2.94% | +2.68% | +41.47% | +97.65% | +212.86% | +163.38% | +385.04% | -24.46% | - | 6.37B | |
| +2.15% | +0.24% | +0.11% | -1.02% | -14.86% | -14.06% | -22.40% | -59.22% | -55.02% | 6.11B | |
| +5.02% | +19.61% | +16.32% | -19.91% | -21.30% | -24.33% | +153.06% | +110.04% | +134.94% | 5.38B | |
| -0.60% | +2.51% | -20.75% | -29.37% | -37.38% | -54.84% | -57.86% | -76.87% | - | 5.27B | |
| -1.40% | +0.99% | +4.11% | -11.28% | -15.90% | +2.10% | +48.70% | -46.14% | - | 5.09B | |
| Average | +2.06% | +8.00% | +19.57% | +14.11% | +26.22% | +46.62% | +143.57% | +74.81% | +941.29% | 18.87B | |
| Weighted average by Cap. | +3.06% | +7.55% | +23.79% | +13.88% | +23.79% | +44.68% | +83.36% | +44.40% | +554.01% |
- Stock Market
- Stocks
- UCB Stock
- UNC Stock
- Sector UCB
Select your edition
All financial news and data tailored to specific country editions
